Litcius/Paper detail

Surufatinib: First Approval

Yahiya Y. Syed

2021Drugs46 citationsDOI

Topics & Concepts

MedicineSorafenibPancreatic cancerInternal medicineDrug developmentNeuroendocrine tumorsOncologyCancerDrugPharmacologyHepatocellular carcinomaNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesNeuroblastoma Research and Treatments
Surufatinib: First Approval | Litcius